ArticleEuropean journal of clinical pharmacology2025
Possible increased risks of cholecystitis in patients with idiopathic pulmonary fibrosis treated with nintedanib.
Catherine Kiani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.